Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Apalla, Z., Sotiriou E., Lallas A., Lazaridou E., & Ioannides D. (2013).  Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial.. Clin J Pain. 29(10), 857-64.
APALLA, Z., Chaidemenos G., & Karakatsanis G. (2009).  Nail unit involvement during severe initial pemphigus vulgaris development.. Eur J Dermatol. 19(3), 290-1.
Apalla, Z., Lallas A., Tzellos T., Sidiropoulos T., Lefaki I., Trakatelli M., et al. (2014).  Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma.. Br J Dermatol. 170(4), 809-15.
Apalla, Z., Sotiriou E., Chovarda E., Lefaki I., Devliotou-Panagiotidou D., & Ioannides D. (2010).  Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study.. Br J Dermatol. 162(1), 171-5.
Apalla, Z., Lallas A., Sotiriou E., & Ioannides D. (2013).  Effect of pigmentation on photodynamic therapy.. Lancet Oncol. 14(9), e339-40.
Apalla, Z., Lallas A., Sotiriou E., Lazaridou E., Vakirlis E., & Ioannides D. (2017).  Stellate erosion: the dermoscopic Nikolsky sign?. Eur J Dermatol. 27(6), 659-660.
Apalla, Z., Calzavara-Pinton P., Lallas A., Argenziano G., Kyrgidis A., Crotti S., et al. (2016).  Histopathological study of perilesional skin in patients diagnosed with nonmelanoma skin cancer.. Clin Exp Dermatol. 41(1), 21-5.
Apalla, Z., Lallas A., Sotiriou E., Lazaridou E., Vakirlis E., Trakatelli M., et al. (2016).  Farmers develop more aggressive histologic subtypes of basal cell carcinoma. Experience from a Tertiary Hospital in Northern Greece.. J Eur Acad Dermatol Venereol. 30 Suppl 3, 17-20.
Apalla, Z., Nikolaidou C., Lallas A., Sotiriou E., Lazaridou E., Venizelos I., et al. (2018).  Clinicopathologically problematic melanocytic tumors: a case-based review.. Dermatol Pract Concept. 8(4), 306-313.
Apostolidis, A., Kirana P-S., Chiu G., Link C., Tsiouprou M., & Hatzichristou D. (2009).  Gender and age differences in the perception of bother and health care seeking for lower urinary tract symptoms: results from the hospitalised and outpatients' profile and expectations study.. Eur Urol. 56(6), 937-47.
Apostolidis, S. A., Michalopoulos A. A., Hytiroglou P., Papadopoulos B. N., Fachantidis E. P., Basdanis G. A., et al. (2000).  Prevention of blood-transfusion-induced impairment of anastomotic healing by leucocyte depletion in rats.. Eur J Surg. 166(7), 562-7.
Apostolidis, A., Rantell A., Anding R., Kirschner-Hermanns R., & Cardozo L. (2017).  How does lower urinary tract dysfunction (LUTD) affect sexual function in men and women? ICI-RS 2015-Part 2.. Neurourol Urodyn. 36(4), 869-875.
Apostolidis, A., Rahnama'i M. S., Fry C., Dmochowski R., & Sahai A. (2016).  Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014.. Neurourol Urodyn. 35(2), 293-8.
Apostolidis, A. (2015).  Words of wisdom. Re: Intrathecal administration of botulinum toxin type a improves urinary bladder function and reduces pain in rats with cystitis.. Eur Urol. 67(4), 816.
Apostolidis, A. (2019).  Is there enough evidence to support sacral neuromodulation as a viable treatment option in children and adolescents with neurogenic lower urinary tract dysfunction?. World J Urol. 37(12), 2811-2812.
Apostolidis, N., Bogdanis G. C., Kostopoulos N., Souglis A., & Papadopoulos C. (2014).  Changes in the lipid profile of elite basketball and soccer players after a match.. Res Sports Med. 22(1), 100-10.
Apostolidis, A., Wagg A., A'i M. S. Rahnam, Panicker J. N., Vrijens D., & von Gontard A. (2018).  Is there "brain OAB" and how can we recognize it? International Consultation on Incontinence-Research Society (ICI-RS) 2017.. Neurourol Urodyn. 37(S4), S38-S45.
Apostolidis, A., & Cameron A. P. (2020).  Neurourological Management After Failed Intradetrusor OnabotulinumtoxinA Injections.. Eur Urol Focus. 6(5), 814-816.
Apostolidis, S., Papavramidis T. S., Zatagias A., Michalopoulos A., Papadopoulos V. N., Paramythiotis D., et al. (2008).  Hematemesis, a very rare presentation of solid pseudo-papillary tumors of the pancreas: a case report.. J Med Case Rep. 2, 271.
Apostolidis, A. (2017).  Combination treatments for overactive bladder refractory to first-line pharmacotherapy: do they meet expectations?. BJU Int. 120(4), 459-460.
Apostolidis, A., Papaefstathiou E., & Gatsos S. (2020).  Intravesical Botox for overactive bladder; how to minimize complications and manage failures.. Curr Drug Targets.
Apostolidis, A. (2013).  Male lower urinary tract symptoms: a riddle waiting to be solved.. Eur Urol. 64(3), 408-10.
Apostolidis, A., Papaefstathiou E., & Gatsos S. (2020).  Intravesical Botox for Overactive Bladder: How to Minimize Complications and Manage Failures. Current Drug Targets. 21(15), 1527 - 1536.
Apostolidis, A. (2015).  Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?. Curr Drug Targets. 16(11), 1187-97.
Apostolidis, A., Thompson C., Yan X., & Mourad S. (2013).  An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity.. World J Urol. 31(6), 1469-74.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές